Center for Molecular Immunology - CIM

News


Mostrar

Registros

News
Celebrating the 24th Anniversary images/Content/noticias/bc10eb12-0063-45dc-892d-feae6596d0c8.jpg https://www.facebook.com/pg/cim.cuba/posts/ Friday, December 7, 2018
Meeting of scientists to treat cancer images/Content/noticias/498e058f-defd-477e-a581-9f8cd88e93f5.jpg http://www.orientesetv.com/reunion-de-cientificos-para-tratar-el-cancer/?fbclid=IwAR1A54Oms_MKc85FvLwCfYIZfP-LOa2x6fXBZJ1SXtov1xLdcFRjUvPz-G0 Friday, December 7, 2018
Congratulations to all our doctors images/Content/noticias/24c22280-c6a6-4c1f-a44b-22c392e9b852.jpg https://www.facebook.com/pg/cim.cuba/posts/ Friday, December 7, 2018
The CIM vs COVID19 images/Content/noticias/a35d81f3-8d1d-42d1-b152-82fc939358b4.jpg Monday, May 11, 2020
Cuban mothers of science images/Content/noticias/bd73bf89-55d7-4aa8-91b1-1921abe0562c.jpg Monday, May 11, 2020
Internal campaign for energy efficiency "Put your energy" images/Content/noticias/37bc3b68-1ec2-45c0-b7e4-5ed556c4b247.png Monday, May 11, 2020
Monoclonal antibody Itolizumab makes its contribution against COVID-19 images/Content/noticias/224b9eaa-fec1-4ce2-a425-6697044f08f8.jpg Tuesday, May 12, 2020
CIM news vs COVID-19 by Telesur images/Content/noticias/f5deb15e-d7ba-434e-9825-8b65a9122a9c.png Wednesday, May 13, 2020
Cuban biotech 's new challenges images/Content/noticias/caeb760c-7f09-409f-be92-c95544c15554.png Wednesday, May 13, 2020
CIM Scientific Council evaluates clinical trial of Itolizumab images/Content/noticias/b5123476-4fd0-471b-adc9-667555d620ca.jpg Wednesday, May 13, 2020
Mostrando 10 de 44 registros
telefono
Phone Board:
53-7-2717933
General Direction:
53-7-2714335
pin
15 Street and 216 Street, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba
pin
Postal Code:
11 600
Post Office Box:
16 040
mapa

Spot

Video

Bulletin CIM

¡Stay informed of our latest news!

Captcha

Cancel subscription

Frequent Questions

How can I access the therapeutic vaccines against lung cancer?


Cuba has 2 therapeutic vaccines for advanced lung cancer: CIMAvax EGF ® and VAXIRA® (Racotumomab). Both therapeutic vaccines have a health record in the indication of advanced non-small cell lung cancer (NSCLC) stage III and IV, after the first line of chemotherapy. The main clinical benefit of these vaccines has been demonstrated in an increase in survival and improvement in quality of life, as well as a broad safety profile. How to get vaccines? Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value. -Cuban Medical Services. Web page: www.smcsalud.cu .; E-mail: smc@smcsalud.cu Telephone: (537) 209-0977 Fax: (537) 203-1590. You can also make your request for care stating the reason for your request, a medical summary and personal data directly to: International Clinic of the Hermanos Ameijeiras Hospital. Calle San Lázaro # 701 esq. a Belascoaín, Centro Habana, La Habana, C.P: 10400, Cuba. Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu International Health Center - La Pradera Calle 15 e / 222 A y 234, Reparto Siboney, Playa Municipality, Havana, Cuba Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercio@cislapradera.cu   If you want a treatment outside of Cuba. You can contact the following companies with commercial rights in the region for CIMAvax EGF® DELTA Laboratories S.A. Colombia. General Manager: Mr. Alejandro Castaño. Address: Cra. 46 # 19 Sur 117 Medellín, Colombia, South America. Tel. + 57-4-334 40 33. Cell: +57 - 311-301 8257 E-mail: alejandrodelta@deltamedecine.com Skype: Alejandrodelta. URL: www.deltamedicine.com   Libra Laboratorios, Paraguay S.A Commercial Manager: Mr. Pablo Moreira. Address: Pedro Ciancio 1443 between Santiago and San Cosme B Jara Asunción Tel. (595-21) 228 370. Cell: (595) 986 679300 E-mail: pmoreira@lablibra.com

Mas preguntas frecuentes...

Poll

Welcome to the CIM survey, we value your opinion and thank you for dedicating your time

We would love to know how you like our site
Excellent
50% (22871 votes)
Very Good
32% (14757 votes)
Good
5% (2685 votes)
Regular
11% (5095 votes)
Bad
0% (272 votes)